ExitValue.ai

ACQUIRED · 2025

Who Acquired OPKO / BioReference Health (Clinical Diagnostics Business)?

Labcorp · $192.5M · 2025

The acquisition

OPKO / BioReference Health (Clinical Diagnostics Business) was acquired by Labcorp in 2025 for $192.5M.

OPKO / BioReference Health (Clinical Diagnostics Business) at time of acquisition

Revenue

$92.5M

Deal value

$192.5M

Own a laboratory services business? See what it's worth.

Labcorp acquired OPKO / BioReference Health (Clinical Diagnostics Business) for $192.5M. Get an M&A-grade EBITDA range and sellability score for your own business, benchmarked against 25,592 real transactions. 2 minutes, no signup.

  • Sellability score with 5-driver breakdown and lift estimates
  • Named comparable M&A transactions in your sub-vertical
  • AI-written analysis grounded in your specific inputs
Run my valuation analysis →

Other acquisitions by Labcorp

Recent transactions by the same buyer — context on their deal flow and footprint.

Similar laboratory services acquisitions

More on laboratory services valuations

Sourced from SEC filings and press releases. Full deal page

Citation: ExitValue.ai. (2025). OPKO / BioReference Health (Clinical Diagnostics Business) acquired by Labcorp. https://exitvalue.ai/acquired/opko-bioreference-health-clinical-diagnostics-business